Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen

Diabetes, Obesity and Metabolism

Volumn 8, Issue 5, 2006, Pages 517-523

  de Boer, H ^a   Keizers, R ^a   Jansen, M ^a   Verschoor, L ^a   Ruineman Koerts, J ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Diabetes mellitus type 2; Glimepiride; Insulin aspart; Weight gain

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; INSULIN ASPART; LONG ACTING INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT DISORDER; DOSE RESPONSE; DRUG EFFICACY; DRUG SUBSTITUTION; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERINSULINISM; LONG TERM CARE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEIN BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 33746900769     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00537.x     Document Type: Article

References (21)

1. Mäkimattila SS, Nikkilä K, Yki-Järvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 1999; 42: 406-412.
2. Yki-Järvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001; 24: 758-767.
3. Groop L, Widén E, Franssila-Kallunki A et al. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 diabetes mellitus. Diabetologia 1989; 32: 599-605.
4. Sinha A, Formica C, Tsalamandris C et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabet Med 1996; 13: 40-46.
5. Rigalleau V, Delafaye C, Baillet L et al. Composition of insulin-induced body weight gain in diabetic patients: A bio-impedance study. Diabetes Metab 1999; 25: 321-328.
6. Bagg W, Plank LD, Gamble G, Drury PL, Sharpe N, Braatvedt GD. The effects of intensive glycemic control on body composition in patients with type 2 diabetes. Diabetes Obes Metab 2001; 3: 410-416.
7. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 1988; 37: 15-21.
8. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes. Diabetes Care 1993; 16: 21-31.
9. Yki-Järvinen Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 2000; 23: 1130-1136.
10. Fritsche A, Schweitzer MA, Häring HU. Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. Ann Int Med 2003; 138: 952-959.
11. Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial. Diabetes Care 2003; 26: 3080-3086.
12. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 1975; 55: 1278-1283.
13. Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 2000; 85: 4491-4499.
14. Porksen N, Grofte T, Greisen J et al. Human insulin release processes by intraportal sampling. Am J Physiol Endocrinol Metab 2002; 282: E695-E702.
15. Shiskho PI, Kovalev PA, Goncharov VG, Zajarny IU. Comparison of peripheral and portal vein routes of insulin infusion in IDDM patients. Diabetes 1992; 41: 1042-1049.
16. De Boer H, Jansen M, Koerts J, Verschoor L. Prevention of weight gain in type 2 diabetes requiring insulin treatment. Diabetes Obes Metab 2004; 6: 114-119.
17. DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean non-insulin-dependent diabetic subjects. J Clin Endocrinol Metab 1991; 73: 1294-1301.
18. Gastaldelli A, Miyazaki Y, Pettiti M et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002; 87: 50985103.
19. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002; 283: E1135-E1143.
20. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 1996; 45: 454-462.
21. Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Int Med 1999; 130: 389-396.